Sentinel lymph node biopsy in melanoma: Our 8-year clinical experience in a single French institute (2002-2009)

Background Since the introduction of sentinel lymph node biopsy (SLNB), its use as a standard of care for patients with clinically node-negative cutaneous melanoma remains controversial. We wished to evaluate our experience of SLNB for melanoma.